Carcinoma Unknow Primary: treatment with gemcitabine, docetaxel, and capecitabine (GTX) an evaluation and treatment study of the Cancer Institute of New Jersey Oncology Group
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 26 May 2015
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary) ; Gemcitabine (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2005 New trial record.